We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
(+14%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
9.66%
Top 10 Holdings %
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$197M |
| 2 |
Alibaba
BABA
|
+$190M |
| 3 |
Amazon
AMZN
|
+$161M |
| 4 |
GoDaddy
GDDY
|
+$135M |
| 5 |
Walt Disney
DIS
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 2 |
Zoetis
ZTS
|
+$96.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$69.5M |
| 4 |
Cadence Design Systems
CDNS
|
+$64.2M |
| 5 |
ANSS
Ansys
ANSS
|
+$60.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.88% |
| 2 | Consumer Discretionary | 23.99% |
| 3 | Technology | 11.1% |
| 4 | Financials | 8.14% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Best Buy
BBY
$19.1B
| $31.7M | 0.26% |
454,009
+169,688
| +60% | +$11.8M |
|
|
WUBA
77
DELISTED
58.com Inc
WUBA
| $31.7M | 0.26% |
509,130
-361,708
| -42% | -$23.3M |
|
|
MLNX
78
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $30.9M | 0.25% |
279,257
+219,366
| +366% | +$25.3M |
|
|
PARA
79
DELISTED
Paramount Global Class B
PARA
| $30.8M | 0.25% |
617,549
+607,390
| +5,979% | +$30.1M |
|
80
Netflix
NFLX
$303B
| $30.5M | 0.25% |
829,850
+775,980
| +1,440% | +$28M |
|
|
VAR
81
DELISTED
Varian Medical Systems, Inc.
VAR
| $30.4M | 0.25% |
223,181
-3,221
| -1% | -$430K |
|
82
NeoGenomics
NEO
$2.02B
| $29.8M | 0.25% |
1,358,313
+1,129,043
| +492% | +$24.8M |
|
|
AMED
83
DELISTED
Amedisys
AMED
| $29.6M | 0.24% |
243,708
+23,205
| +11% | +$2.75M |
|
84
Equifax
EFX
$22.2B
| $29.1M | 0.24% |
+215,364
| New | +$27M |
|
85
NetApp
NTAP
$33.9B
| $29.1M | 0.24% |
471,698
+459,496
| +3,766% | +$31M |
|
86
Adobe
ADBE
$105B
| $28.9M | 0.24% |
98,100
-86,984
| -47% | -$24.2M |
|
87
Encompass Health
EHC
$11.4B
| $28.8M | 0.24% |
572,090
+430,939
| +305% | +$20.9M |
|
88
Lowe's Companies
LOW
$122B
| $28.7M | 0.24% |
284,294
+261,841
| +1,166% | +$27.6M |
|
89
PTC
PTC
$15.1B
| $28.6M | 0.24% |
318,318
-334,259
| -51% | -$30M |
|
90
Vail Resorts
MTN
$5.66B
| $28.5M | 0.23% |
127,873
-33,730
| -21% | -$7.49M |
|
|
MASI
91
DELISTED
Masimo
MASI
| $27.6M | 0.23% |
185,758
-47,294
| -20% | -$6.49M |
|
92
Quest Diagnostics
DGX
$26B
| $27.6M | 0.23% |
271,530
+25,916
| +11% | +$2.49M |
|
93
Dollar Tree
DLTR
$24.7B
| $27.1M | 0.22% |
252,304
+120,015
| +91% | +$12.6M |
|
|
PRAH
94
DELISTED
PRA Health Sciences, Inc.
PRAH
| $27M | 0.22% |
272,380
+181,867
| +201% | +$17.4M |
|
95
Nomad Foods
NOMD
$1.76B
| $26.8M | 0.22% |
1,256,621
+248,988
| +25% | +$5.22M |
|
96
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$165M
| $26.3M | 0.22% |
15,828
+2,153
| +16% | +$3.82M |
|
97
CALL
iShares MSCI EAFE ETF
EFA
$76.3B
| $26.2M | 0.22% |
415,400
+99,000
| +31% | +$6.48M |
|
98
Pentair
PNR
$10.7B
| $25.6M | 0.21% |
687,975
+208,175
| +43% | +$7.9M |
|
99
Baxter International
BAX
$12.7B
| $25.2M | 0.21% |
307,584
+296,353
| +2,639% | +$23M |
|
100
Bruker
BRKR
$9.41B
| $25.2M | 0.21% |
503,780
-638,946
| -56% | -$26.9M |
|
Similar funds
Marshall Wace's Q2 2019 Portfolio in Review
As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.
- Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
- Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
- Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
- Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
- Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.
Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.